Ixiaro receives FDA approval for the prevention of Japanese Encephalitis
Links shared publicly online about this topic.
- 2,152total visits
Ixiaro receives FDA approval for the prevention of Japanese Encephalitis
Basel, March 30, 2009 - The United States Food and Drug Administration has approved Ixiaro vaccine for the prevention of Japanese Encephalitis (JE). The vaccine will be marketed in the US as Ixiaro by Novartis Vaccines. JE, a mosquito-borne flaviviral infection, is a devastating disease that results in 10,000-15,000 deaths annually[1],[2] and is a potential threat for travelers to Asia.
View full resource at novartis.com
Tags: Vaccination, Infection, Encephalitis, Disease and Condition, Drug, FDA, Vaccine, Novartis
Most Recently Shared on March 30, 2009 at 9:42 pm By:
Ixiaro® receives FDA approval for the prevention of Japanese Encephalitis: http://twurl.nl/vxgxxb
Advertisement
